GC62830
AG-024322
Also known as N-[[5-[3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-indazol-5-yl]-4-methyl-3-pyridinyl]methyl]ethanamine
AG-024322 is a potent ATP-competitive pan-CDK inhibitor against cell cycle kinases CDK1, CDK2, and CDK4 with Ki values in the 1-3 nM range· AG-024322 displays broad-spectrum anti-tumor activity and clear target modulation?in vivo· AG-024322 induces cell apoptosis
ChemicalCAS837364-57-5MW418.44FormulaC23H20F2N6
- CAS number
- 837364-57-5
- Molecular weight
- 418.44
- Formula
- C23H20F2N6
- InChIKey
- MEKASOQEXYKAKM-UHFFFAOYSA-N
- Catalogue number
- GC62830
- Brand
- GLPBIO
Computed properties PubChem CID 135413565 · XLogP 3.7 · TPSA 82.3 Ų · H-bond donors 3
- XLogP
- 3.7
- TPSA
- 82.3 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 31
SMILES CCNCC1=CN=CC(=C1C)C2=CC3=C(C=C2)NN=C3C4=NC5=C(N4)C=C(C=C5F)F
Computed descriptors from PubChem (CID 135413565), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il